Ignite Creation Date:
2024-05-06 @ 2:03 PM
Last Modification Date:
2024-10-26 @ 1:24 PM
Study NCT ID:
NCT04209621
Status:
TERMINATED
Last Update Posted:
2022-03-09
First Post:
2019-12-21
Brief Title:
Duvelisib for Ibrutinib-Resistant Chronic Lymphocytic LeukemiaSmall Lymphocytic Lymphoma
Sponsor:
Organization:
National Institutes of Health Clinical Center CC